|Articles|April 1, 2013
- BioPharm International-04-01-2013
- Volume 26
- Issue 4
BioPharm International, April 2013 Issue (PDF)
Click the title above to open the BioPharm International April 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 12 years ago
Milestones and Moderate Progress in 2012 Drug Approvalsover 12 years ago
Custom-Cell Products: Diversified In Vitro Modelsover 12 years ago
Benchmarking: Don't Just Run the Numbers, Understand the Processover 12 years ago
Strategic Partnering for Manufacturingover 12 years ago
State of Quality and Compliance in the Biopharmaceutical Industryover 12 years ago
Navigating Emerging Markets — Latin Americaover 12 years ago
Manufacturers Under Pressure to Manage Painkillersover 12 years ago
Prescribing Caution for Biosimilarsover 12 years ago
Financing InnovationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
